Genetic discrimination on the agenda at US hearing
This article was originally published in Clinica
Taking an unusually activist stance, a federal public health advisory committee has scheduled a public hearing on genetic discrimination in the hope that stories from the public will help get anti-discrimination legislation through the US House.
You may also be interested in...
The companies think they can build out the indications for zuranalone and SAGE-324 faster and more broadly and commercialize the drugs more effectively as partners.
The guidance document allows manufacturers to promote their dry-heat systems for mask bioburden reduction if they meet certain standards.
The US Medicare agency is letting ambulatory surgical centers and patient homes be reimbursed as in-patient hospitals for patient care purposes during the pandemic.